132 results match your criteria: "Hopitaux Universitaires Saint-Louis[Affiliation]"
Eur J Heart Fail
July 2018
Imperial College, London, UK.
This paper provides a practical clinical application of guideline recommendations relating to the inpatient monitoring of patients with acute heart failure, through the evaluation of various clinical, biomarker, imaging, invasive and non-invasive approaches. Comprehensive inpatient monitoring is crucial to the optimal management of acute heart failure patients. The European Society of Cardiology heart failure guidelines provide recommendations for the inpatient monitoring of acute heart failure, but the level of evidence underpinning most recommendations is limited.
View Article and Find Full Text PDFEur J Heart Fail
August 2018
Inserm UMR-S 942, Paris, France.
Eur J Heart Fail
June 2018
U942 INSERM, Assistance Publique - Hôpitaux de Paris, Paris, France.
Heart Fail Rev
July 2018
Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Heart failure is a complex disease process, the manifestation of various cardiac and noncardiac abnormalities. General treatment approaches for heart failure have remained the same over the past decades despite the advent of novel therapies and monitoring modalities. In the same vein, the readmission rates for heart failure patients remain high and portend a poor prognosis for morbidity and mortality.
View Article and Find Full Text PDFAnaesth Crit Care Pain Med
June 2018
Service USIR-SRPR, hospital de Forcilles, 77150 Férolles-Atilly, France.
Eur Respir J
March 2018
Division of Infectious Diseases, Dept of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
J Med Microbiol
April 2018
Service de Médecine Interne, Maladies Infectieuses et Immunologie Clinique, Hôpital Robert Debré, Avenue Général Koenig, 51100 Reims, France.
is rarely observed in human chronic infections. A strain was isolated from a skin biopsy of chronic dermohypodermitis in a 21-year-old woman without an immunocompromised state. As this strain was viable one month after a cat scratch despite treatment by amoxicillin-clavulanic acid, we compared this strain's growth rate, amoxicillin Minimal Inhibitory and Bactericidal Concentrations (MIC and MBC), resistance to serum and ability to activate neutrophil granulocytes with those of control strains isolated during acute infections in humans without previous antibiotics exposure.
View Article and Find Full Text PDFEur J Heart Fail
June 2018
Inserm UMR-S 942, Paris, France.
Crit Care
January 2018
Department of Anesthesiology, Critical Care and Burn Unit, Hôpitaux Universitaires Saint Louis-Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France.
J Card Fail
March 2018
U942 INSERM, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Anesthesia and Critical care. Hôpitaux Universitaires Saint-Louis-Lariboisière, Paris, France; University Paris Diderot, Sorbonne Paris Cité, Paris, France. Electronic address:
Crit Care
January 2018
Department of Anesthesiology, Critical Care and Burn Unit, Hôpitaux Universitaires Saint Louis-Lariboisière, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot-Paris 7, Sorbonne Paris Cité, UMR-S 942, INSERM, Paris, France.
Background: Intensive care unit (ICU) survivors have reduced long-term survival compared to the general population. Identifying parameters at ICU discharge that are associated with poor long-term outcomes may prove useful in targeting an at-risk population. The main objective of the study was to identify clinical and biological determinants of death in the year following ICU discharge.
View Article and Find Full Text PDFEur J Intern Med
May 2018
Inserm, CHRU Nancy, Université de Lorraine, CIC-1433, Epidémiologie Clinique, F-54000, Nancy, France; Université de Lorraine, EA 4360 Apemac, F-54000, Nancy, France. Electronic address:
Background: We aimed to assess the effectiveness of recommended drug prescriptions at hospital discharge on 1-year mortality in patients with heart failure (HF) and reduced ejection fraction (HFREF).
Materials And Methods: We used data from the EPICAL2 cohort study. HF patients ≥18years old with left ventricular ejection fraction (LVEF) <40% and alive at discharge were included and followed up for mortality.
JACC Heart Fail
January 2018
University Paris Diderot, Paris, France; Pôle de Recherche et D'enseignement Supérieur Sorbonne Paris Cité, Paris, France; INSERM U942, Paris, France; Department of Anesthesiology, Burn and Critical Care Medicine, Hôpitaux Universitaires Saint-Louis-Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address:
Eur J Heart Fail
April 2018
U942 INSERM, Assistance Publique - Hôpitaux de Paris, Paris, France.
Eur Heart J
January 2018
Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland.
In acute heart failure (AHF) syndromes significant respiratory failure (RF) is essentially seen in patients with acute cardiogenic pulmonary oedema (ACPE) or cardiogenic shock (CS). Non-invasive ventilation (NIV), the application of positive intrathoracic pressure through an interface, has shown to be useful in the treatment of moderate to severe RF in several scenarios. There are two main modalities of NIV: continuous positive airway pressure (CPAP) and pressure support ventilation (NIPSV) with positive end expiratory pressure.
View Article and Find Full Text PDFCerebellum
April 2018
AP-HP, Genetic Department, Pitié-Salpêtrière University Hospital, Paris, France.
Friedreich ataxia, an autosomal recessive mitochondrial disease, is the most frequent inherited ataxia. Many studies have attempted to identify cognitive and affective changes associated with the disease, but conflicting results have been obtained, depending on the tests used and because many of the samples studied were very small. We investigated personality and neuropsychological characteristics in a cohort of 47 patients with genetically confirmed disease.
View Article and Find Full Text PDFEur J Heart Fail
December 2017
Inserm UMR-S 942, Paris, France.
Anaesth Crit Care Pain Med
October 2017
Service USIR-SRPR, hospital de Forcilles, 77150 Férolles-Atilly, France.
Clin Microbiol Infect
April 2018
National Reference Center for Mycobacteria and Antimycobacterial Resistance, Paris, France.
Objectives: Mycobacterium chimaera is a recently described nontuberculous mycobacterium belonging to the Mycobacterium avium complex (MAC). Because this species is implicated in a worldwide outbreak due to contaminated heater-cooler unit water tanks during open-heart surgery, it has become mandatory for clinical microbiology laboratories to be able to differentiate M. chimaera from the other MAC species, especially M.
View Article and Find Full Text PDFMed Mal Infect
September 2017
Inserm Sorbonne universités, UPMC université Paris 06, CR7, U1135, centre d'immunologie et des maladies infectieuses, CIMI, Team E13 (bactériologie), 91, boulevard de l'hôpital, 75013 Paris, France; Centre national de référence des mycobactéries et de la résistance des mycobactéries aux antituberculeux (CNR-MyRMA), bactériologie-hygiène, hôpitaux universitaires Pitié-Salpêtrière-Charles-Foix, AP-HP, 47-83, boulevard de l'hôpital, 75013 Paris, France; Hôpitaux universitaires Saint-Louis-Lariboisière, AP-HP, 2, rue Ambroise-Paré, 75010 Paris, France.
Objective: Molecular methods predict drug resistance several weeks before phenotypic methods and enable rapid implementation of appropriate therapeutic treatment. We aimed to detail the most representative molecular tools used in routine practice for the rapid detection of resistance to antituberculosis drugs among Mycobacterium tuberculosis strains.
Materials And Methods: The molecular diagnosis of resistance to antituberculosis drugs in clinical samples or from in vitro cultures is based on the detection of the most common mutations in the genes involved in the development of resistance in M.
Acta Anaesthesiol Scand
July 2017
Département d'Anesthésie - Réanimation - SMUR, Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Saint Louis - Lariboisière, Paris, France.
Introduction: During general anesthesia, arterial hypotension is frequent and may be an important contributor to perioperative morbidity. We assessed the effect of a 5 μg bolus of Norepinephrine (NA) when compared with 50 μg bolus of Phenylephrine (PE) administered to treat hypotension during maintenance anesthesia, on MAP, derived cardiac output and arterial stiffness parameters.
Methods: Patients scheduled for a neurosurgical procedure under general anesthesia were prospectively included.
Gynecol Obstet Fertil Senol
May 2017
Service de gynécologie obstétrique, hôpital Lariboisière, hôpitaux universitaires Saint-Louis-Lariboisière-Fernand-Widal, faculté de médecine Paris VII Diderot, 2, rue Ambroise-Paré, 75475 Paris cedex 10, France.
Aims: To identify differences in clinical epidemiology, in-hospital management and 1-year outcomes among patients hospitalized for acute heart failure (AHF) and enrolled in the European Society of Cardiology Heart Failure Long-Term (ESC-HF-LT) Registry, stratified by clinical profile at admission.
Methods And Results: The ESC-HF-LT Registry is a prospective, observational study collecting hospitalization and 1-year follow-up data from 6629 AHF patients. Among AHF patients enrolled in the registry, 13.
Heart Lung
August 2017
Department of Emergency Medicine, Vanderbilt University, Nashville, VA, USA.
Background: Dyspnea is the most common presenting symptom in patients with acute heart failure (AHF), but is difficult to quantify as a research measure. The URGENT Dyspnea study compared 3 scales: (1) 10 cm VAS, (2) 5-point Likert, and (3) a 7-point Likert (both VAS and 5-point Likert were recorded in the upright and supine positions). However, the minimal clinically important difference (MCID) to patients has not been well established.
View Article and Find Full Text PDFEur Heart J
March 2019
Inserm, Centre d'Investigations Cliniques- 1433, and Inserm U1116; CHRU Nancy; Université de Lorraine; Association Lorraine pour le Traitement de l'Insuffisance Rénale, Institut lorrain du Cœur et des Vaisseaux Louis Mathieu, 4 rue du Morvan, Nancy, France.
Although cardiovascular disease is a major health burden for patients with chronic kidney disease, most cardiovascular outcome trials have excluded patients with advanced chronic kidney disease. Moreover, the major cardiovascular outcome trials that have been conducted in patients with end-stage renal disease have not demonstrated a treatment benefit. Thus, clinicians have limited evidence to guide the management of cardiovascular disease in patients with chronic kidney disease, particularly those on dialysis.
View Article and Find Full Text PDF